| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
1,734,653,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
2,851,500 |
Avg
Vol: |
1,304,659 |
| 52
Week Range: |
$0.0035 - $0.0035 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Related Products |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Nutra Pharma is a holding company. Co. engages in the acquisition, licensing and commercialization of pharmaceutical products and technologies as well as homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, autoimmune and infectious diseases. Co.'s subsidiary, ReceptoPharm, Inc., has developed four homeopathic drugs for the treatment of pain: Nyloxin® and Nyloxin® Extra Strength, Pet Pain-Away™, and Equine Nyloxin®. Co. also has developed two drug candidates: RPI-78M, to treat neurological diseases and autoimmune diseases; and RPI-MN, to treat viral diseases including Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome and Herpes.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Deitsch Rik J |
President, CEO |
• • • |
2016-12-19 |
4 |
B |
$0.01 |
$75,000 |
D/D |
15,000,000 |
43,298,859 |
3.23 |
- |
|
| Deitsch Rik J |
President, CEO |
• • • |
2016-07-05 |
4 |
B |
$0.01 |
$100,500 |
D/D |
15,000,000 |
28,298,859 |
3.23 |
- |
|
| Deitsch Rik J |
President, CEO |
• • • |
2016-06-28 |
4 |
A |
$0.01 |
$54,000 |
D/D |
4,000,000 |
13,298,859 |
|
- |
|
| Oran Dan |
Director |
– • – |
2016-06-17 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
15,200,000 |
|
- |
|
| Deitsch Rik J |
President, CEO |
• • • |
2015-06-13 |
4 |
A |
$0.19 |
$740,000 |
D/D |
4,000,000 |
9,298,859 |
|
- |
|
| Deitsch Rik J |
President, CEO |
• • • |
2014-12-11 |
4 |
A |
$0.24 |
$121,656 |
D/D |
506,900 |
5,298,859 |
|
- |
|
6 Records found
|
1
|
Page 1 of 1 |
|
|
